Evidence map›Paper›PMID 30847424›Full record

ArticleJACC. Basic to translational science2019

Circulating Pro-Vascular Progenitor Cell Depletion During Type 2 Diabetes: Translational Insights Into the Prevention of Ischemic Complications in Diabetes.

Daniella C Terenzi, Mohammed Al-Omran, Adrian Quan, Hwee Teoh, Subodh Verma, David A Hess

5 registry-linked trialsAbstract read
In one paragraph

Article in JACC. Basic to translational science, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 5 registered trials, which are not on this map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05870462 phase4unknown statusstarted 2023, after this paper: background citation

Semaglutide and Vascular Regeneration in People With Diabetes and/or Obesity

Ran2023Enrolled100Registered outcomes4Posted comparisons0ConditionsAtherosclerosis, Cardiovascular Diseases, Diabetes Mellitus, Type 2, ObesityArmsSemaglutide Pen Injector
Open the trial in the graph
NCT04562467 phase4completednot on this mapstarted 2020, after this paper: background citation

The Icosapent Ethyl and Prevention of Vascular Regenerative Cell Exhaustion Study

TypeinterventionalSponsorCanadian Medical and Surgical Knowledge Translation Research GroupRan2020 to 2023Enrolled70ConditionsCardiovascular Diseases, Cardiovascular Risk Factor, Triglycerides High, Diabetes Mellitus, Type 2ArmsIcosapent Ethyl 1000 MG Oral Capsule [Vascepa]
NCT05410834 unknown statusnot on this mapstarted 2022, after this paper: background citation

The Characterization of Pro-vascular Regenerative Cell Exhaustion in Women With Polycystic Ovarian Syndrome

TypeobservationalSponsorCanadian Medical and Surgical Knowledge Translation Research GroupRan2022 to 2023Enrolled30ConditionsPolycystic Ovary Syndrome
NCT06108388 unknown statusnot on this mapstarted 2023, after this paper: background citation

Functional Investigation of Endothelial Function and Regenerative Cell Exhaustion in Type 2 Diabetes

TypeobservationalSponsorCanadian Medical and Surgical Knowledge Translation Research GroupRan2023 to 2026Enrolled90ConditionsDiabetes Mellitus, Type 2
NCT06626659 completednot on this mapstarted 2024, after this paper: background citation

Lipoprotein (a) and Vascular Regenerative Cell Content

TypeobservationalSponsorCanadian Medical and Surgical Knowledge Translation Research GroupRan2024 to 2024Enrolled40ConditionsCardiovascular Diseases, Atherosclerosis Cardiovascular Disease, Ischemic Heart Disease, Dyslipidemia
3 · Its place in the literature

Who cites it

17 citing papers in PubMed.

  1. Trial
  2. Trial
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Bone marrow vasculature advancedFrontiers in cardiovascular medicine · 2023
    Review
  12. Review
  13. Article
  14. Article
  15. Review
  16. Review
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Daniella C TerenziDivision of Cardiac Surgery, Keenan Research Centre for Biomedical Science and Li Ka Shing Knowledge Institute of St. Michael's Hospital, Toronto, Ontario, Canada.
Mohammed Al-OmranInstitute of Medical Science, University of Toronto, Toronto, Ontario, Canada.
Adrian QuanDivision of Cardiac Surgery, Keenan Research Centre for Biomedical Science and Li Ka Shing Knowledge Institute of St. Michael's Hospital, Toronto, Ontario, Canada.
Hwee TeohDivision of Cardiac Surgery, Keenan Research Centre for Biomedical Science and Li Ka Shing Knowledge Institute of St. Michael's Hospital, Toronto, Ontario, Canada.
Subodh VermaDivision of Cardiac Surgery, Keenan Research Centre for Biomedical Science and Li Ka Shing Knowledge Institute of St. Michael's Hospital, Toronto, Ontario, Canada.
David A HessDivision of Vascular Surgery, Keenan Research Centre for Biomedical Science and Li Ka Shing Knowledge Institute of St. Michael's Hospital, Toronto, Ontario, Canada.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Detection of vascular regenerative cell exhaustion is required to combat ischemic complications during type 2 diabetes mellitus (T2D). We used high aldehyde dehydrogenase (ALDH) activity and surface marker co-expression to develop a high-throughput flow cytometry-based assay to quantify circulating proangiogenic and proinflammatory cell content in the peripheral blood of individuals with T2D. Circulating proangiogenic monocytes expressing anti-inflammatory M2 markers were decreased in patients with T2D. Individuals with longer duration of T2D exhibited reduced frequencies of circulating proangiogenic ALDH

Indexed as

aldehyde dehydrogenaseALDH, aldehyde dehydrogenaseangiogenesisBM, bone marrowHbA1c, glycosylated hemoglobinischemiaprogenitor cellsROS, reactive oxygen speciesSSC, side scatterT2D, type 2 diabetes mellitustype 2 diabetesWnt, wingless related integration site

Identifiers

PMID30847424
PMCPMC6390504

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.